nandrolone has been researched along with Bone Loss, Perimenopausal in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 22 (75.86) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaves, PH; Frisoli, A; Pinheiro, MM; Szejnfeld, VL | 1 |
| Cederholm, T; Söderqvist, A; Tengstrand, B; Tidermark, J | 1 |
| Androulakis, C; Charalambaki, Z; Lyritis, GP; Magiasis, B; Tsakalakos, N | 1 |
| Christiansen, C; Overgaard, K; Ravn, P; Spencer, EM | 1 |
| Christiansen, C; Hassager, C; Jensen, LT; Pødenphant, J; Thomsen, K | 1 |
| Butturini, L; Cortenraad, MG; Passeri, M; Pedrazzoni, M; Pioli, G; Ruys, AH | 1 |
| Birkenhäger, JC; Birkenhäger-Frenkel, DH; Erdtsieck, RJ; Kooy, PP; Mulder, P; Pols, HA; van Kuijk, C; Zeelenberg, J | 1 |
| Birkenhäger, JC; Brocaar, MP; Gerritsma, EJ; Hakkesteegt, MM | 1 |
| Christiansen, C; Hassager, C | 1 |
| Adami, S; Rossini, M | 1 |
| Durbridge, TC; Need, AG; Nordin, BE | 1 |
| Aerssens, J; Dequeker, J; Geusens, P; Osman, AA; Schot, LP; Van Audekercke, R | 1 |
| Buirski, G; Flicker, L; Hopper, JL; Larkins, RG; Lichtenstein, M; Wark, JD | 1 |
| Carlson, CS; Guidry, M; Jerome, CP; Obasanjo, IO; Power, RA; Register, TC; Weaver, DS | 1 |
| Adami, S; Braga, V; Guidi, G; Lippi, G; Ruzzenente, O | 1 |
| Bolanca, S; Cvijetić, S; Dekanić, D; Korsić, M | 1 |
| Chhaparwal, M; Saraf, ML | 1 |
| Jerome, CP | 1 |
| Skouby, SO | 1 |
| Schneider, HP | 1 |
| Perry, CM; Wellington, K | 1 |
| Birkenhäger, JC; Birkenhäger-Frenkel, DH; Erdtsieck, RJ; Gerritsma, EJ; Kooy, PP; Luiken, GP; Mulder, P; van Kuik, C; van Veen, LC; Zeelenberg, J | 1 |
| Holló, I; Horváth, C; Kollin, E; Szathmári, M; Szücs, J | 2 |
| Birkenhäger, JC | 1 |
| Christiansen, C; Hartwell, D; Hassager, C; Overgaard, K; Pødenphant, JR; Riis, BJ | 1 |
| Davies, UM; Hesp, R; Katz, D; McNally, E; Reeve, J | 1 |
| AgnusDei, D; Gennari, C; Gonnelli, S; Nardi, P | 1 |
| Christiansen, C; Hassager, C; Pødenphant, J; Riis, BJ | 1 |
4 review(s) available for nandrolone and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
The rationale for a wider range of progestogens.
Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome | 2000 |
The role of antiandrogens in hormone replacement therapy.
Topics: Androgen Antagonists; Biological Availability; Body Weight; Chemistry, Pharmaceutical; Cognition; Coronary Disease; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Nandrolone; Osteoporosis, Postmenopausal; Patient Selection; Progesterone Congeners; Treatment Outcome | 2000 |
Estradiol valerate/dienogest.
Topics: Administration, Oral; Animals; Bone Density; Clinical Trials as Topic; Drug Combinations; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; In Vitro Techniques; Middle Aged; Nandrolone; Osteoporosis, Postmenopausal; Postmenopause | 2002 |
[Estrogens, anabolic steroids and postmenopausal osteoporosis: what are the facts?].
Topics: Aged; Anabolic Agents; Bone Density; Estrogen Replacement Therapy; Female; Humans; Nandrolone; Osteoporosis, Postmenopausal | 1991 |
17 trial(s) available for nandrolone and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Androgens; Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Nandrolone; Osteoporosis, Postmenopausal; Probability; Prospective Studies; Reference Values; Risk Assessment; Statistics, Nonparametric; Treatment Outcome | 2005 |
Effects of protein-rich supplementation and nandrolone on bone tissue after a hip fracture.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Anabolic Agents; Biomarkers; Body Weight; Bone Density; Dietary Proteins; Dietary Supplements; Female; Fracture Healing; Hip Fractures; Humans; Nandrolone; Osteocalcin; Osteoporosis, Postmenopausal; Treatment Outcome | 2007 |
Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.
Topics: Aged; Bone Density; Calcium; Creatinine; Double-Blind Method; Female; Humans; Hydroxycholecalciferols; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Pain; Spinal Fractures | 1994 |
Insulin-like growth factors I and II in healthy women with and without established osteoporosis.
Topics: Adult; Aged; Aging; Biomarkers; Bone Density; Bone Regeneration; Calcitonin; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Linear Models; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Radioimmunoassay; Reference Values | 1995 |
The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
Topics: Aged; Anabolic Agents; Biomarkers; Bone and Bones; Bone Resorption; Collagen; Collagen Type I; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Peptides | 1994 |
Effects of nandrolone decanoate on bone mass in established osteoporosis.
Topics: Alkaline Phosphatase; Anabolic Agents; Bone Density; Double-Blind Method; Female; Humans; Hydroxyproline; Lumbar Vertebrae; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteocalcin; Osteoporosis, Postmenopausal; Pain Measurement | 1993 |
Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate.
Topics: Aged; Anabolic Agents; Biomarkers; Body Mass Index; Bone Density; Cholesterol; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Patient Compliance; Spinal Fractures | 1994 |
Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year.
Topics: Aged; Anabolic Agents; Case-Control Studies; Edema; Estrogen Replacement Therapy; Female; Humans; Laryngoscopy; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Phonation; Postmenopause; Prospective Studies; Time Factors; Virilism; Voice; Voice Disorders; Voice Quality | 1994 |
Epidemiology, biochemistry and some results with treatment of postmenopausal osteoporosis.
Topics: Aged; Aged, 80 and over; Anabolic Agents; Body Composition; Bone Density; Cross-Sectional Studies; Denmark; Double-Blind Method; Female; Humans; Incidence; Injections, Intramuscular; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal | 1993 |
Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
Topics: Administration, Intranasal; Aged; Aged, 80 and over; Anabolic Agents; Bone Density; Calcitonin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Prospective Studies | 1997 |
Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
Topics: Anabolic Agents; Bone Density; Double-Blind Method; Female; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal | 1998 |
Primate models of osteoporosis.
Topics: Alkaline Phosphatase; Anabolic Agents; Animals; Bone Resorption; Disease Models, Animal; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Macaca fascicularis; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroid Hormone; Treatment Outcome | 1998 |
Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?
Topics: Aged; Alkaline Phosphatase; Bone Density; Calcium; Cholesterol; Cholesterol, HDL; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hydroxyproline; Middle Aged; Nandrolone; Osteocalcin; Osteoporosis, Postmenopausal; Single-Blind Method; Voice Disorders | 1992 |
Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine.
Topics: Aged; Bone Density; Calcitonin; Calcium; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Nandrolone; Osteoporosis, Postmenopausal; Phosphates; Spinal Fractures | 1992 |
Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin.
Topics: Aged; Anabolic Agents; Calcitonin; Calcitriol; Calcium; Creatinine; Double-Blind Method; Drug Combinations; Estradiol; Female; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Norethindrone; Osteoporosis, Postmenopausal; Patient Compliance; Phosphates; Vitamin D; Vitamin D-Binding Protein | 1990 |
Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
Topics: Alkaline Phosphatase; Anabolic Agents; Bone Density; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxyproline; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Random Allocation | 1989 |
Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
Topics: Aged; Anabolic Agents; Body Mass Index; Bone Density; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Lipoproteins; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Time Factors | 1989 |
8 other study(ies) available for nandrolone and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Anabolic steroids in corticosteroid-induced osteoporosis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anabolic Agents; Bone Density; Bone Resorption; Female; Humans; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis; Osteoporosis, Postmenopausal; Prospective Studies | 1993 |
Anabolic steroids in postmenopausal osteoporosis.
Topics: Adult; Aged; Anabolic Agents; Androgens; Bone Density; Calcium; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal | 1993 |
Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.
Topics: Anabolic Agents; Animals; Biomechanical Phenomena; Bone Density; Bone Remodeling; Collagen; Dose-Response Relationship, Drug; Female; Femur; Humans; Insulin-Like Growth Factor I; Nandrolone; Nandrolone Decanoate; Osteocalcin; Osteoporosis, Postmenopausal; Ovariectomy; Ovary; Rats; Rats, Wistar | 1993 |
The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
Topics: Absorptiometry, Photon; Acid Phosphatase; Alkaline Phosphatase; Amino Acids; Anabolic Agents; Animals; Biomarkers; Body Composition; Bone Density; Bone Development; Bone Diseases, Metabolic; Disease Models, Animal; Estradiol; Female; Femur; Humans; Ilium; Isoenzymes; Lumbar Vertebrae; Macaca fascicularis; Nandrolone; Nandrolone Decanoate; Osteocalcin; Osteoporosis, Postmenopausal; Ovariectomy; Random Allocation; Tartrate-Resistant Acid Phosphatase | 1997 |
Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis.
Topics: Anabolic Agents; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Lipoprotein(a); Lipoproteins; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Risk Factors | 1997 |
Effects of combined treatment with etidronate, nandrolone-decanoate and calcium on bone mineral density in postmenopausal women.
Topics: Anabolic Agents; Bone Density; Calcium; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Retrospective Studies | 1998 |
[Treatment of postmenopausal osteoporosis with low doses of calcitonin and a calcitonin-anabolic combination].
Topics: Aged; Calcitonin; Drug Therapy, Combination; Female; Fractures, Spontaneous; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Spinal Fractures | 1992 |
Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
Topics: Bone Density; Calcium; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Lumbar Vertebrae; Nandrolone; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptide Fragments; Progesterone; Radius; Sodium Fluoride; Spinal Injuries; Teriparatide | 1990 |